Hien Thi Tran

Array ( [id] => 6545780 [patent_doc_number] => 20020110853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-15 [patent_title] => 'TWEAK receptor' [patent_app_type] => new [patent_app_number] => 09/883777 [patent_app_country] => US [patent_app_date] => 2001-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19594 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20020110853.pdf [firstpage_image] =>[orig_patent_app_number] => 09883777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7443400 [patent_doc_number] => 20040009475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-15 [patent_title] => 'Method of determining a chemotherapeutic regimen based on ERCC1 and TS expression' [patent_app_type] => new [patent_app_number] => 09/877178 [patent_app_country] => US [patent_app_date] => 2001-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12705 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20040009475.pdf [firstpage_image] =>[orig_patent_app_number] => 09877178 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1150198 [patent_doc_number] => 06770622 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-03 [patent_title] => 'N-terminally truncated galectin-3 for use in treating cancer' [patent_app_type] => B2 [patent_app_number] => 09/877790 [patent_app_country] => US [patent_app_date] => 2001-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 30 [patent_no_of_words] => 14085 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/770/06770622.pdf [firstpage_image] =>[orig_patent_app_number] => 09877790 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 833630 [patent_doc_number] => 07396920 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-08 [patent_title] => 'Tumour suppressor and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/297641 [patent_app_country] => US [patent_app_date] => 2001-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 18133 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/396/07396920.pdf [firstpage_image] =>[orig_patent_app_number] => 10297641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6096561 [patent_doc_number] => 20020052316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-02 [patent_title] => 'Bax-mediated apoptosis modulating reagents and methods' [patent_app_type] => new [patent_app_number] => 09/876204 [patent_app_country] => US [patent_app_date] => 2001-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11747 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20020052316.pdf [firstpage_image] =>[orig_patent_app_number] => 09876204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 867465 [patent_doc_number] => 07364726 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-29 [patent_title] => 'Pharmaceutical composition for cancer treatment containing cells that express a membrane cytokine' [patent_app_type] => utility [patent_app_number] => 09/875349 [patent_app_country] => US [patent_app_date] => 2001-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 23671 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/364/07364726.pdf [firstpage_image] =>[orig_patent_app_number] => 09875349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 432047 [patent_doc_number] => 07264820 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-04 [patent_title] => 'Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokline' [patent_app_type] => utility [patent_app_number] => 09/875823 [patent_app_country] => US [patent_app_date] => 2001-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 23666 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/264/07264820.pdf [firstpage_image] =>[orig_patent_app_number] => 09875823 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 584197 [patent_doc_number] => 07449557 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-11 [patent_title] => 'Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy' [patent_app_type] => utility [patent_app_number] => 09/873403 [patent_app_country] => US [patent_app_date] => 2001-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 65 [patent_figures_cnt] => 65 [patent_no_of_words] => 28481 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/449/07449557.pdf [firstpage_image] =>[orig_patent_app_number] => 09873403 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6131298 [patent_doc_number] => 20020077289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-20 [patent_title] => 'Angiostatin and endostatin binding proteins and methods of use' [patent_app_type] => new [patent_app_number] => 09/873676 [patent_app_country] => US [patent_app_date] => 2001-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 23412 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20020077289.pdf [firstpage_image] =>[orig_patent_app_number] => 09873676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 755116 [patent_doc_number] => 07019108 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-03-28 [patent_title] => 'Method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within MMP-2' [patent_app_type] => utility [patent_app_number] => 09/872165 [patent_app_country] => US [patent_app_date] => 2001-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9749 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/019/07019108.pdf [firstpage_image] =>[orig_patent_app_number] => 09872165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6635890 [patent_doc_number] => 20020086812 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-04 [patent_title] => 'Methods and compositions for diagnosis and treatment of cancer' [patent_app_type] => new [patent_app_number] => 09/870844 [patent_app_country] => US [patent_app_date] => 2001-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 37624 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20020086812.pdf [firstpage_image] =>[orig_patent_app_number] => 09870844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 414825 [patent_doc_number] => 07279156 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-09 [patent_title] => 'Apoptotic entities for use in treatment of endothelium dysfunction disorders' [patent_app_type] => utility [patent_app_number] => 09/866569 [patent_app_country] => US [patent_app_date] => 2001-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4838 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/279/07279156.pdf [firstpage_image] =>[orig_patent_app_number] => 09866569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5844130 [patent_doc_number] => 20020132228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-19 [patent_title] => 'Phage antibodies' [patent_app_type] => new [patent_app_number] => 09/865048 [patent_app_country] => US [patent_app_date] => 2001-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3315 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20020132228.pdf [firstpage_image] =>[orig_patent_app_number] => 09865048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6082321 [patent_doc_number] => 20020082217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'Therapeutic anti-melanoma compounds' [patent_app_type] => new [patent_app_number] => 09/862260 [patent_app_country] => US [patent_app_date] => 2001-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19473 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20020082217.pdf [firstpage_image] =>[orig_patent_app_number] => 09862260 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6241337 [patent_doc_number] => 20020044936 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-18 [patent_title] => 'Method of inhibiting angiogenesis and tumor growth and preventing tumor growth and metastases' [patent_app_type] => new [patent_app_number] => 09/855886 [patent_app_country] => US [patent_app_date] => 2001-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4752 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20020044936.pdf [firstpage_image] =>[orig_patent_app_number] => 09855886 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6882635 [patent_doc_number] => 20010049107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-06 [patent_title] => 'Polyclonal antibody libraries' [patent_app_type] => new [patent_app_number] => 09/855316 [patent_app_country] => US [patent_app_date] => 2001-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 21314 [patent_no_of_claims] => 103 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20010049107.pdf [firstpage_image] =>[orig_patent_app_number] => 09855316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 648687 [patent_doc_number] => 07115265 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-10-03 [patent_title] => 'Four genetic tumor markers specific for human glioblastoma' [patent_app_type] => utility [patent_app_number] => 09/853880 [patent_app_country] => US [patent_app_date] => 2001-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7943 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/115/07115265.pdf [firstpage_image] =>[orig_patent_app_number] => 09853880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6462356 [patent_doc_number] => 20020150580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'Recombinant antibodies for human therapy' [patent_app_type] => new [patent_app_number] => 09/850165 [patent_app_country] => US [patent_app_date] => 2001-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 16841 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20020150580.pdf [firstpage_image] =>[orig_patent_app_number] => 09850165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6593142 [patent_doc_number] => 20020042066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-11 [patent_title] => 'Novel human selenium-binding protein' [patent_app_type] => new [patent_app_number] => 09/841758 [patent_app_country] => US [patent_app_date] => 2001-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 17802 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20020042066.pdf [firstpage_image] =>[orig_patent_app_number] => 09841758 [rel_patent_id] =>[rel_patent_doc_number] =>)